株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己免疫疾患診断:疾患区分 (全身性・局所性)・地域別の動向分析・市場予測

Autoimmune Disease Diagnostics Market Size & Forecast By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics Disease Diagnostics), By Region, And Trend Analysis From 2014 To 2025

発行 Grand View Research, Inc. 商品コード 478609
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
自己免疫疾患診断:疾患区分 (全身性・局所性)・地域別の動向分析・市場予測 Autoimmune Disease Diagnostics Market Size & Forecast By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics Disease Diagnostics), By Region, And Trend Analysis From 2014 To 2025
出版日: 2017年02月03日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の自己免疫疾患診断の市場を調査し、市場の定義と概要、市場成長推進因子・抑制因子の分析、疾患区分・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

  • 市場概要

第3章 市場の可変因子・動向・展望

  • 市場区分
    • 成長推進因子
    • 成長阻害因子
  • 普及率・成長の見通しのマッピング
  • SWOT分析
  • ポーターの産業分析

第4章 市場推計・動向分析:タイプ別

  • 市場の動き:タイプ別
  • 全身性自己免疫疾患の診断
    • 関節リウマチ
      • 市場規模の推移と予測
    • 強直性脊椎炎
      • 市場規模の推移と予測
    • 全身性エリテマトーデス (SLE)
      • 市場規模の推移と予測
    • その他
      • 市場規模の推移と予測
  • 局所性疾患の診断
    • 多発性硬化症
      • 市場規模の推移と予測
    • 1型糖尿病
      • 市場規模の推移と予測
    • 橋本病
      • 市場規模の推移と予測
    • 特発性血小板減少性紫斑病 (ITP)
      • 市場規模の推移と予測
    • その他
      • 市場規模の推移と予測

第5章 市場推計・動向分析:地域・タイプ別

  • 市場シェアの実績・予測:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
  • アジア太平洋
    • 日本
    • 中国
    • インド
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 南アフリカ

第6章 競合環境

  • 市場参入形態のカテゴリー
  • 企業プロファイル
目次
Product Code: 978-1-68038-292-1

The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

Further key findings from the study suggest:

Localized autoimmune disease diagnostics was the largest segment in 2015 owing to high usage for type 1 diabetes and idiopathic thrombocytopenic purpura

Type 1 diabetes is estimated to grow at a significant growth rate of over 4.0% in localized disease type segment

Systemic disease diagnostics is anticipated to witness lucrative CAGR of around 5.0% over the forecast period due to increasing R&D for the development of novel diagnostic biomarkers for the treatment of rheumatoid arthritis and systemic lupus erythematosus

Rheumatoid arthritis is one of the most recurring autoimmune disorders further demanding high amount of rapid diagnostics for exploring better alternative treatments

North America was the largest regional market in 2015. High market penetration rate of technologically advanced products and increased lab automation rate are some of the factors contributing to its large share

Asia Pacific region is anticipated to grow at the fastest CAGR of above 4.0% over the forecast period owing to increasing focus on type 1 diabetes diagnosis

Some of the key players of this market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU. Diagnostics; Inova Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased database:
    • 1.1.2 GVR's internal database
  • 1.2 Research Methodology
  • 1.3 Geographic Scope & Assumptions
  • 1.4 Region-wise Market Calculation
    • 1.4.1 Region-wise market: Base estimates
    • 1.4.2 Global market: CAGR calculation
  • 1.5 Region-based Segment Share Calculation
  • 1.6 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Autoimmune Disease Diagnostics Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Presence of research funding programs
      • 3.1.1.2 Presence of favorable government initiatives
      • 3.1.1.3 Growing patient awareness levels
      • 3.1.1.4 Technological innovation in the form of lab automation
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Autoimmune Disease Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Autoimmune Disease Diagnostics: Type Estimates & Trend Analysis

  • 4.1 Autoimmune Disease Diagnostics Market: Type Movement Analysis
  • 4.2 Systemic Autoimmune Disease Diagnostics
    • 4.2.1 Systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
    • 4.2.2 Rheumatoid arthritis diagnostics
      • 4.2.2.1 Rheumatoid arthritis diagnostics market, 2013 - 2025 (USD Million)
    • 4.2.3 Ankylosing spondylitis diagnostics
      • 4.2.3.1 Ankylosing spondylitis diagnostics market, 2013 - 2025 (USD Million)
    • 4.2.4 Systemic lupus erythematosus (SLE) diagnostics
      • 4.2.4.1 Systemic lupus erythematosus (SLE) diagnostics market, 2013 - 2025 (USD Million)
    • 4.2.5 Other systemic autoimmune disease diagnostics
      • 4.2.5.1 Other systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • 4.3 Localized Disease Diagnostics
    • 4.3.1 Localized disease diagnostics market, 2013 - 2025 (USD Million)
    • 4.3.2 Multiple sclerosis diagnostics
      • 4.3.2.1 Multiple sclerosis diagnostics market, 2013 - 2025 (USD Million)
    • 4.3.3 Type 1 diabetes diagnostics
      • 4.3.3.1 Type 1 diabetes diagnostics market, 2013 - 2025 (USD Million)
    • 4.3.4 Hashimoto's Thyroiditis diagnostics
      • 4.3.4.1 Hashimoto's Thyroiditis diagnostics market, 2013 - 2025 (USD Million)
    • 4.3.5 Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
      • 4.3.5.1 Idiopathic thrombocytopenic purpura diagnostics market, 2013 - 2025 (USD Million)
    • 4.3.6 Other localized autoimmune disease diagnostics
      • 4.3.6.1 Other diagnostics market, 2013 - 2025 (USD Million)

Chapter 5 Autoimmune Disease Diagnostics: Regional Estimates & Trend Analysis, by Type

  • 5.1 Autoimmune Disease Diagnostics Market Share, By Region, 2013 & 2020
  • 5.2 North America
    • 5.2.1 U.S.
      • 5.2.1.1 U.S autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.2.2 Canada
      • 5.2.2.1 Canada autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.3.2 UK
      • 5.3.2.1 UK autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.4.2 Japan
      • 5.4.2.1 Japan autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • 5.6 MEA
    • 5.6.1 MEA autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa autoimmune disease diagnostics market, 2013 - 2024 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Market Participation Categorization
  • 6.2 Company Profiles
    • 6.2.1 Abbott Laboratories
      • 6.2.1.1 Company overview
      • 6.2.1.2 Financial performance
      • 6.2.1.3 Product benchmarking
      • 6.2.1.4 Strategic initiatives
    • 6.2.2 Siemens Healthineers
      • 6.2.2.1 Company overview
      • 6.2.2.2 Product benchmarking
      • 6.2.2.3 Strategic initiatives
    • 6.2.3 Roche Diagnostics
      • 6.2.3.1 Company overview
      • 6.2.3.2 Product benchmarking
      • 6.2.3.3 Strategic initiatives
    • 6.2.4 Beckman Coulter, Inc.
      • 6.2.4.1 Company overview
      • 6.2.4.2 Product benchmarking
    • 6.2.5 SQI Diagnostics, Inc.
      • 6.2.5.1 Company overview
      • 6.2.5.2 Product benchmarking
      • 6.2.5.3 Strategic initiatives
    • 6.2.6 EUROIMMUN AG
      • 6.2.6.1 Company overview
      • 6.2.6.2 Product benchmarking
      • 6.2.6.3 Strategic initiatives
    • 6.2.7 AESKU.Diagnostics GmbH & Co. KG
      • 6.2.7.1 Company overview
      • 6.2.7.2 Product benchmarking
      • 6.2.7.3 Strategic initiatives
    • 6.2.8 Inova Diagnostics
      • 6.2.8.1 Company overview
      • 6.2.8.2 Product benchmarking
      • 6.2.8.3 Strategic initiatives
    • 6.2.9 Crescendo Bioscience, Inc.
      • 6.2.9.1 Company overview
      • 6.2.9.2 Product benchmarking
      • 6.2.9.3 Strategic initiatives
    • 6.2.10 bioMerieux SA
      • 6.2.10.1 Company overview
      • 6.2.10.2 Financial performance
      • 6.2.10.3 Product benchmarking
      • 6.2.10.4 Strategic initiatives
    • 6.2.11 Bio-Rad Laboratories, Inc.
      • 6.2.11.1 Company overview
      • 6.2.11.2 Financial performance
      • 6.2.11.3 Product benchmarking
      • 6.2.11.4 Strategic initiatives
    • 6.2.12 Hemagen Diagnostics, Inc.
      • 6.2.12.1 Company overview
      • 6.2.12.2 Product benchmarking
    • 6.2.13 Quest Diagnostics
      • 6.2.13.1 Company overview
      • 6.2.13.2 Financial performance
      • 6.2.13.3 Product benchmarking
      • 6.2.13.4 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 List of NIH funding programs, 2013
  • TABLE 3 Potential biomarkers and their potential applications in treating SLE
  • TABLE 4 ITP prevalence, by condition
  • TABLE 5 North America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 6 North America systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 7 North America localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 8 U.S. autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 9 U.S. systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 10 U.S. localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 11 Canada autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 12 Canada systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 13 Canada localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 14 Europe autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 15 Europe systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 16 Europe localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 17 UK autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 18 UK systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 19 UK localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 20 Germany autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 21 Germany systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 22 Germany localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 23 Asia Pacific autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 24 Asia Pacific systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 25 Asia Pacific localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 26 Japan autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 27 Japan systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 28 Japan localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 29 China autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 30 China systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 31 China localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 32 India autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 33 India systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 34 India localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 35 Latin America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 36 Latin America systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 37 Latin America localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 38 Brazil autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 39 Brazil systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 40 Brazil localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 41 Mexico autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 42 Mexico systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 43 Mexico localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 44 MEA autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 45 MEA systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 46 MEA localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 47 South Africa autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 48 South Africa systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
  • TABLE 49 South Africa localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary, 2015
  • FIG. 6 Market trends & outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Disease incidence rates per 100,000, by type, 2015
  • FIG. 10 Total autoimmune related NIH funding, 2011 - 2014 (USD Million)
  • FIG. 11 Market restrain relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Autoimmune disease diagnostics market type outlook key takeaways
  • FIG. 16 Autoimmune disease diagnostics market: Type movement analysis
  • FIG. 17 Implementation of the AMP RA/SLE program, by research phase
  • FIG. 18 Global systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 19 Global rheumatoid arthritis diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 20 Global ankylosing spondylitis diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 21 Global Systemic Lupus Erythematosus (SLE) diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 22 Global other systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 23 Global Localized disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 24 Global multiple sclerosis diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 25 Global type 1 diabetes diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 26 Global Hashimoto's thyroiditis diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 27 Global idiopathic thrombocytopenic purpura diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 28 Global other diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 29 Regional market place: Key takeaways
  • FIG. 30 North America autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 31 U.S. autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 32 Canada autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 33 Europe autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 34 UK autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 35 Germany autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 36 Asia Pacific autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 37 Japan autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 38 China autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 39 India autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
  • FIG. 40 Latin America autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 41 Brazil autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 42 Mexico autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 43 MEA autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 44 South Africa autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
  • FIG. 45 Participant categorization